Biomerica Inc (BMRA) stock forecast · rev $4.5M
Biomerica Inc (BMRA) is a medical devices company listed on US.
This BMRA forecast page states what the cached financials imply — not a price target and not a guarantee. Biomerica Inc outlooks on Lician start from reported revenue and the latest filing, then you decide.
Latest reported BMRA revenue for 2026-05-31 was $4.5M. Net income was -$3.8M. Revenue was down 16.2% from 2025-05-31 to 2026-05-31. BMRA currently screens at market cap $8.0M.
The near-term path: Revenue was down 16.2% from 2025-05-31 to 2026-05-31. A forecast that ignores that change is just a story.
BMRA currently screens at market cap $8.0M. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next BMRA 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the BMRA stock page.
Not investment advice.